je.st
news
Tag: study
Rich nations study details massive insurance program ease 3rd World climate change damages
2015-06-10 12:00:00| Climate Ark Climate Change & Global Warming Newsfeed
ClimateWire: Countries already bearing the brunt of extreme weather events are cautiously optimistic about a new insurance scheme designed by the world's wealthiest nations to protect about 400 million people in the world's most vulnerable communities. Official details about the disaster-risk reduction program, announced as part of the Group of Seven (G-7) decisions this week, remain sparse. But a top Munich Re official involved with the plan told ClimateWire that Germany has kicked in with an initial 150 million...
Tags: world
details
change
program
Novartis says study shows secukinumab works in spinal inflammation condition
2015-06-10 09:36:28| Biotech - Topix.net
ZURICH: Novartis AG said one-year results of its drug secukinumab show it is effective in treating patients with ankylosing spondylitis , a debilitating joint condition of the spine.
Tags: works
study
shows
condition
Olay Unveils MDE Study at World Derm Congress
2015-06-10 07:08:00| Happi Breaking News
Finds biological commonalities among women and specific gene expression changes that impact skin aging.
Tags: world
study
congress
unveils
New Study: PFSweb, Inc. (PFSW) - Financial and Strategic SWOT Analysis Review
2015-06-09 21:46:28| Logistics - Topix.net
The company provides integrated technologies, professional services, and a logistics infrastructure to deliver unique and branded customer experiences. It offers agency services, technology services, infrastructure services and technology ecosystem.
Tags: review
study
analysis
financial
No Heart Safety Issues Seen With Merck Januvia Diabetes Drug: Study
2015-06-09 17:50:34| Biotech - Topix.net
Details of a large heart safety study presented on Monday appear to give Merck and Co's diabetes drug Januvia a clean bill of health, possibly setting the stage for a return to sales growth for the drugmaker's biggest product. Merck in April said the study, called Tecos, of 14,724 patients with type 2 diabetes and a history of heart disease demonstrated that adding Januvia to usual care did not increase major heart problems any more than adding a placebo, removing a cloud that has been holding back sales of the medicine and the company's share price.
Tags: issues
study
heart
safety
Sites : [458] [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] [476] [477] next »